Title |
Linking serum malondialdehyde with dyslipidemia in patients with metabolic syndrome
|
Authors |
Gadigeppa H Chittaragi1, Dileep Khubya2,* & Veluri Ganesh3
|
Affiliation |
1Department of Medicine, Dr. N Y Tasgaonkar Institute of Medical Science, Diksal, Maharashtra, India; 2Department of Biochemistry, Sri Siddhartha Institute of Medical Sciences, T Begur, Nelamangala, Karnataka, India; 3Department of Biochemistry, PES University Institute of Medical Sciences and Research, Electronic City, Bengaluru, Karnataka, India; *Corresponding author
|
|
Gadigeppa H Chittaragi - E-mail:
chittaragihospital@gmail.com |
Article Type |
Research Article
|
Date |
Received June 1, 2025; Revised June 30, 2025; Accepted June 30, 2025, Published June 30, 2025
|
Abstract |
Dyslipidemia and obesity is becoming an increasingly serious public health issue. Therefore, it is of interest to determine the serum levels of malondialdehyde (MDA) with dyslipidemia in patients with metabolic syndrome. The routine demographic, anthropometric and the biochemical parameters analyzed. Additionally, the degree of lipid peroxidation was measured by serum levels of malondialdehyde (MDA). The body mass index, systolic and diastolic blood pressure, fasting blood sugars, lipid profile significantly elevated in metabolic syndrome patients when compared to healthy controls. The serum MDA levels significantly elevated and correlated positively with abdominal hyperglycemia, hypertension, obesity and negatively with HDL (p=0.0001**). Thus, the early detection of people at risk for getting metabolic syndrome can be improved by measuring the MDA biomarker. |
Keywords |
Dyslipidemia, malondialdehyde (MDA), metabolic syndrome
|
Citation |
Chittaragi et al. Bioinformation 21(6): 1693-1698 (2025)
|
Edited by |
P Kangueane
|
ISSN |
0973-2063
|
Publisher |
|
License |
This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
|
|